Global trends and modifiable risk factors for atopic dermatitis incidence: Insights from GBD 2021
- PMID: 40740413
- PMCID: PMC12308001
- DOI: 10.1016/j.jacig.2025.100532
Global trends and modifiable risk factors for atopic dermatitis incidence: Insights from GBD 2021
Abstract
Background: Global patterns in atopic dermatitis (AD) incidence and their associations with modifiable risk factors remain unclear.
Objective: We sought to analyze global trends in AD incidence and identify associated socioeconomic, environmental, and lifestyle factors contributing to its global disparities and epidemics.
Methods: Data on AD in 204 countries and territories from 1990 to 2021 were extracted from the Global Burden of Diseases Study 2021. Age-standardized incidence rates (ASIRs) were calculated by sex and region. Socioeconomic development was measured by the Sociodemographic Index, a composite indicator of income, education, and fertility. Modifiable risk factors-including high body mass index, low physical activity, air pollution, and unhealthy diets-were quantified using summary exposure values, reflecting the population-level exposure to each risk. Dietary risks included diet high in sugar-sweetened beverages, processed meat, and sodium, and low intake of whole grains. Relationships between ASIRs and summary exposure values were independently assessed using restricted cubic spline regression.
Results: In 2021, 16.0 million new cases of AD were recorded globally, with the highest ASIRs in high-income Asia Pacific (474.8 per 100,000 population) and Western Europe (421.7 per 100,000 population) geographically and higher ASIRs in women. AD incidence strongly increased with socioeconomic development. Among modifiable risk factors, high body mass index, low physical activity, and nitrogen dioxide pollution formed positive associations with AD risk. Diets rich in sugar-sweetened beverages, processed meat, and sodium and diet low in whole grains further increased the risk.
Conclusions: Global disparities in AD incidence trends are closely linked to socioeconomic development and modifiable risk factors, including obesity, air pollution, and unhealthy diets. Addressing these factors through targeted public health policies is essential to mitigating the global burden of AD, particularly in industrialized and rapidly developing regions.
Keywords: Atopic dermatitis; Global Burden of Disease study; incidence; risk factors.
© 2025 The Author(s).
Conflict of interest statement
The work was supported by the National Natural Science Foundation of China (42477471) and Natural Science Foundation of Hunan Province (2025JJ20084). Disclosure of potential conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.
Figures




Similar articles
-
Global trends in testicular and prostate cancer among adolescents and young adult males aged 15-49 years, 1990-2021: insights from the GBD study.Sci Rep. 2025 Jul 2;15(1):23388. doi: 10.1038/s41598-025-07361-3. Sci Rep. 2025. PMID: 40603429 Free PMC article.
-
Burden of knee osteoarthritis in China and globally: 1990-2045.BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8. BMC Musculoskelet Disord. 2025. PMID: 40598022 Free PMC article.
-
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7. Lancet Neurol. 2024. PMID: 39304265 Free PMC article.
-
Topical tacrolimus for atopic dermatitis.Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2. Cochrane Database Syst Rev. 2015. PMID: 26132597 Free PMC article.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
References
-
- Langan S.M., Irvine A.D., Weidinger S. Atopic dermatitis. Lancet. 2020;396:345–360. - PubMed
-
- Odhiambo J.A., Williams H.C., Clayton T.O., Robertson C.F., Asher M.I., ISAAC Phase Three Study Group Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251–1258.e23. - PubMed
-
- Barbarot S., Auziere S., Gadkari A., Girolomoni G., Puig L., Simpson E.L., et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73:1284–1293. - PubMed
-
- World Health Organization Ending the neglect to attain the sustainable development goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases. 2022. https://iris.who.int/handle/10665/355448 Available at: - PubMed
-
- Mehrmal S., Uppal P., Giesey R.L., Delost G.R. Identifying the prevalence and disability-adjusted life years of the most common dermatoses worldwide. J Am Acad Dermatol. 2020;82:258–259. - PubMed
LinkOut - more resources
Full Text Sources